Milrinone (STRAGEN) Infusion
Milrinone
1mg/ml
STRAGEN UK LIMITED
| Pack size | 10 Ampoules x 10 ml |
|---|---|
| Dispensing mode | POM |
| Source | UK |
| Agent | PHARMALINK |
| Retail Price | 964.50 AED |
Indications
Milrinone (STRAGEN) Infusion is used for:
Indicated for the treatment of congestive heart failure.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Milrinone :
Mechanism of Action
Milrinone inhibits erythrocyte phosphodiesterase, resulting in an increase in erythrocyte cAMP activity. Subsequently, the erythrocyte membrane becomes more resistant to deformity. Along with erythrocyte activity, Milrinone also decreases blood viscosity by reducing plasma fibrinogen concentrations and increasing fibrinolytic activity.
Note
Milrinone (STRAGEN) 1mg/ml Infusion manufactured by STRAGEN UK LIMITED. Its generic name is Milrinone. Milrinone (STRAGEN) is availble in United Arab Emirates.
Farmaco UAE drug index information on Milrinone (STRAGEN) Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.